SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Andersson Rune 1951) "

Sökning: WFRF:(Andersson Rune 1951)

  • Resultat 1-10 av 80
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Backhaus, Erik, et al. (författare)
  • Antimicrobial susceptibility of invasive pneumococcal isolates from a region in south-west Sweden 1998-2001.
  • 2007
  • Ingår i: Scandinavian journal of infectious diseases. - : Informa UK Limited. - 0036-5548 .- 1651-1980. ; 39:1, s. 19-27
  • Tidskriftsartikel (refereegranskat)abstract
    • Invasive disease caused by antibiotic resistant pneumococci is a worldwide problem. All invasive pneumococcal strains in an area of south-west Sweden with 1.7 million inhabitants were collected prospectively during 1998-2001. Minimum inhibitory concentrations (MICs) were determined by E-test and correlated to serotypes and clinical characteristics. Of 827 strains, 744 (90%) were susceptible (S) to all agents tested and 83 (10%) were indeterminate (I) or resistant (R) to at least 1 agent. 22 isolates (2.7%) were I to penicillin (MIC >0.06 to < or = 1.0 mg/l), but none were R (MIC >1.0 mg/l). Numbers and proportions of decreased susceptibility against other agents tested were as follows: erythromycin R: 30 (3.6%), clindamycin R: 6 (0.7%), tetracycline R: 16 (1.9%), moxifloxacin R: 1 (0.1%), cotrimoxazole I: 17 (2%) and R: 31(4%). Non-susceptibility to at least 1 agent was not correlated with age, clinical manifestation, underlying diseases and outcome. The serotype distribution differed between non-susceptible and susceptible strains. The serotypes in the 7-valent pneumococcal conjugate vaccine covered 42% of all infections and 73% of those caused by non-susceptible strains. In conclusion, the impact of antibiotic resistance in invasive pneumococcal disease remains limited in south-west Sweden.
  •  
2.
  • Emgård, Matilda, 1984, et al. (författare)
  • Co-occurrence of bacteria and viruses and serotype distribution of Streptococcus pneumoniae in the nasopharynx of Tanzanian children below 2 years of age following introduction of the PCV13
  • 2024
  • Ingår i: FRONTIERS IN PUBLIC HEALTH. - 2296-2565. ; 12
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: Pneumococcal conjugate vaccines have reduced severe disease attributed to vaccine-type pneumococci in children. However, the effect is dependent on serotype distribution in the population and disease development may be influenced by co-occurrence of viral and bacterial pathogens in the nasopharynx. Methods: Following introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in Tanzania we performed repeated cross-sectional surveys, including 775 children below 2 years of age attending primary healthcare centers. All children were sampled from nasopharynx and pneumococci were detected by single-target PCR. Pneumococcal serotypes/groups and presence of viruses and other bacteria were determined by two multiplex PCR assays. Results: The prevalence of PCV13 vaccine-type pneumococci decreased by 50%, but residual vaccine-types were still detected in 21% of the children 2 years after PCV13 introduction. An increase in the non-vaccine-type 15 BC was observed. Pneumococci were often co-occurring with Haemophilus influenzae, and detection of rhino/enterovirus was associated with higher pneumococcal load. Discussion: We conclude that presence of residual vaccine-type and emerging non-vaccine-type pneumococci in Tanzanian children demand continued pneumococcal surveillance. High co-occurrence of viral and bacterial pathogens may contribute to the disease burden and indicate the need of multiple public health interventions to improve child health in Tanzania.
  •  
3.
  • Wennerås, Christine, 1963, et al. (författare)
  • Distinct Inflammatory Mediator Patterns Characterize Infectious and Sterile Systemic Inflammation in Febrile Neutropenic Hematology Patients
  • 2014
  • Ingår i: Plos One. - : Public Library of Science (PLoS). - 1932-6203. ; 9:3
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Invasive infections and sterile tissue damage can both give rise to systemic inflammation with fever and production of inflammatory mediators. This makes it difficult to diagnose infections in patients who are already inflamed, e.g. due to cell and tissue damage. For example, fever in patients with hematological malignancies may depend on infection, lysis of malignant cells, and/or chemotherapy-induced mucosal damage. We hypothesized that it would be possible to distinguish patterns of inflammatory mediators characterizing infectious and non-infectious causes of inflammation, respectively. Analysis of a broad range of parameters using a multivariate method of pattern recognition was done for this purpose. Methods: In this prospective study, febrile (>38 degrees C) neutropenic patients (n = 42) with hematologic malignancies were classified as having or not having a microbiologically defined infection by an infectious disease specialist. In parallel, blood was analyzed for 116 biomarkers, and 23 clinical variables were recorded for each patient. Using O-PLS (orthogonal projection to latent structures), a model was constructed based on these 139 variables that could separate the infected from the non-infected patients. Non-discriminatory variables were discarded until a final model was reached. Finally, the capacity of this model to accurately classify a validation set of febrile neutropenic patients (n = 10) as infected or non-infected was tested. Results: A model that could segregate infected from non-infected patients was achieved based on discrete differences in the levels of 40 variables. These variables included acute phase proteins, cytokines, measures of coagulation, metabolism, organ stress and iron turn-over. The model correctly identified the infectious status of nine out of ten subsequently recruited febrile neutropenic hematology patients. Conclusions: It is possible to separate patients with infectious inflammation from those with sterile inflammation based on inflammatory mediator patterns. This strategy could be developed into a decision-making tool for diverse clinical applications.
  •  
4.
  • Abdulle, Sahra, 1970, et al. (författare)
  • Family support is important for adherence to antiretroviral therapy among HIV positive mothers in Dar es Salaam, Tanzania.
  • 2019
  • Ingår i: CLINICAL MICROBIOLOGY AND RESEARCH. ; 1:1, s. 1-3
  • Tidskriftsartikel (refereegranskat)abstract
    • Adherence to antiretroviral treatment (ART) is of utmost importance to reduce the risk of vertical transmission of HIV. We enrolled 106 patients from two Prevention of mother-to-child transmission (PMTCT) clinics in Dar es Salaam in September- November 2016. Study participants were given structured standardized questionnaires regarding their self-estimated adherence and barriers and enablers to adherence. Good adherence was defined as taking ≥95% of the pills as prescribed. About 70% of the participants achieved this level of adherence. The odds ratios for poor adherence among women with medium and poor family support were 5.69 (95% CI: 1.36-23-75) and 6.86 (95% CI: 1.89-24.96) respectively compared to good support. A large portion of the women failed to reach the high set limit for adherence. Increased spousal involvement and support could help many women to achieve good adherence.
  •  
5.
  • Abraha, Aynalem, et al. (författare)
  • Breaking bad news in cancer care: preferences of patients, family caregivers and general public in Ethiopia
  • 2021
  • Ingår i: International Conference on Communication in Healthcare (ICCH) 2020 Part 2, 15-16 April, 2021.
  • Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
    • This study explores the preferences of cancer patients, family caregivers, and the general public regarding breaking bad news in an Ethiopian oncology setting. The research was conducted at Tikur Anbessa (Black Lion) Specialized Hospital. The sample consists of patients with a confirmed cancer diagnosis, their family caregivers, and representatives from the general public with 150 subjects per cohort. A comparative cross-sectional study design and a multivariable analysis were used. The patients would like to be informed, which contradicts the perceptions of family caregivers. This creates an ethical dilemma for staff in terms of how much they involve their patients in clinical decision-making. The patients also indicate that information not to be withheld from them. In contrast, the general public prefers information about poor life expectancy to be communicated to family only, which may reflect widespread public perception of cancer as a deadly disease. The findings indicate the complexity of communication concerning breaking bad news in oncology care in Ethiopia. It requires oncologists to probe patient attitudes before information disclosure in order to find a balance between involving patients in communication at the same time as keeping a constructive alliance with family caregivers.
  •  
6.
  • Abraha, Aynalem, et al. (författare)
  • Perceptions of cancer patients and their caregivers regarding COVID-19 pandemic in Ethiopia
  • 2021
  • Ingår i: J Clin Oncol 39, 2021 (suppl 15; abstr e24116).
  • Konferensbidrag (refereegranskat)abstract
    • Background: Limited research is available about COVID 19 pandemic in Ethiopia in general and in relation to cancer care in particular. Ethiopia reported the first COVID-19 in March, 2020. The number of cases is increasing, putting much pressure on oncology care. This study examines what the Ethiopian cancer patients and their caregivers knew about COVID 19 after the initial stages of the pandemic. It also assesses the information needs, psychological experiences as well as the impact of pandemic on oncologist-patient-caregiver communication and treatment process. Methods: A cross-sectional study was conducted among 200 participants (100 cancer patients and 100 caregivers) at the initial stage of pandemic (May 1 - June 30, 2020) at Tikur Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia. Data was collected using a pre-tested, structured questionnaire to assess knowledge and perceptions on COVID-19. Ethics approval was obtained from the Ethical Review Board of TASH (04/14/2015) and the Ethical Review Board of Western Sweden (DNR 520-18). Results: The results indicate that though both cancer patients and their caregivers show a high awareness of and knowledge about COVID 19, they need more information about the risks specific to cancer patients. The respondents are also concerned about the risks of pandemic outbreak in Ethiopia and its impact on availability of cancer care treatments in the country. The respondents report experiencing psychological concerns in relation to the pandemic. The higher educated patients and caregivers report being more concerned than the lower educated respondents. Delays in appointments and therapy are the main concerns in relation to cancer care. Further, both patients and caregivers experience that the restrictions on the number of caregivers present during interactions with oncologists negatively influence communication, resulting in relatives being excluded and patients experiencing loneliness and lack of support. Conclusions: Getting a better insight into knowledge and awareness of COVID-19 among cancer patients and their caregivers is essential for managing the effects of pandemic in cancer care. To our knowledge, there was no similar study in Ethiopia. The results of the study contribute to insights into patient and caregiver awareness of COVID 19, essential for adoption of health care protective practices, providing information and managing oncologist-patient-caregiver communication.
  •  
7.
  • Abraha Woldemariam, Aynalem, et al. (författare)
  • Breaking Bad News in Cancer Care: Ethiopian Patients Want More Information Than What Family and the Public Want Them to Have.
  • 2021
  • Ingår i: JCO global oncology. - 2687-8941. ; 7, s. 1341-1348
  • Tidskriftsartikel (refereegranskat)abstract
    • This study explores the preferences of patients with cancer, family caregivers, and the general public regarding breaking bad news in an Ethiopian oncology setting.The study was conducted at Tikur Anbessa (Black Lion) Specialized Hospital. The sample consists of patients with a confirmed cancer diagnosis, their family caregivers, and representatives from the general public with 150 subjects per cohort. The study used a comparative cross-sectional design and multivariable data analysis.The patients would like to be informed, which contradicts the preferences of family caregivers. This creates an ethical dilemma for staff in terms of how much they involve their patients in clinical decision making. The patients also indicate that information should not be withheld from them. By contrast, the general public prefers information about poor life expectancy to be communicated to family only, which may reflect a widespread public perception of cancer as a deadly disease.The findings indicate the complexity of communication-related preferences concerning breaking bad news in oncology care in Ethiopia. It requires oncologists to probe patient attitudes before information disclosure to find a balance between involving patients in communication at the same time as keeping a constructive alliance with family caregivers.
  •  
8.
  •  
9.
  •  
10.
  • Alestig, Kjell, 1931, et al. (författare)
  • Ceftazidime and renal function.
  • 1984
  • Ingår i: The Journal of antimicrobial chemotherapy. - : Oxford University Press (OUP). - 0305-7453 .- 1460-2091. ; 13:2, s. 177-81
  • Tidskriftsartikel (refereegranskat)abstract
    • Glomerular filtration rate (GFR) as measured by 51Chrome-EDTA clearance, decreased with a mean of 10 ml/min during therapy with ceftazidime 2 g bid in 16 patients with initial GFR of 30 to 110 ml/min. A significant increase in the excretion of urinary alanine aminopeptidase was also found. In another three patients with initial GFR of 17-22 ml/min increases in serum creatinine during therapy were noted. These observations indicate that ceftazidime should be used with caution in patients with impaired renal function and not be combined with nephrotoxic drugs until the safety of such combinations has been studied.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 80
Typ av publikation
tidskriftsartikel (73)
konferensbidrag (7)
Typ av innehåll
refereegranskat (70)
övrigt vetenskapligt/konstnärligt (6)
populärvet., debatt m.m. (4)
Författare/redaktör
Andersson, Rune, 195 ... (77)
Skovbjerg, Susann, 1 ... (14)
Olaison, Lars, 1949 (13)
Hogevik, Harriet (7)
Nordén, Rickard, 197 ... (7)
Addissie, Adamu (6)
visa fler...
Gonzales-Siles, Luci ... (6)
Jacobsson, Gunnar, 1 ... (6)
Munthe, Christian, 1 ... (5)
Trollfors, Birger, 1 ... (5)
Backhaus, Erik (5)
Geravandi, Shadi (5)
Linderholm, Barbro, ... (4)
Abraha, Aynalem (4)
Berbyuk Lindström, N ... (4)
Alestig, Kjell, 1931 (4)
Woxenius, Susanne (4)
Birindwa, Archippe M ... (4)
Lindh, Magnus, 1960 (3)
Berg, Stefan, 1959 (3)
Lärstad, Mona, 1971 (3)
Rosengren, Lars, 195 ... (2)
Hansson, Sverker, 19 ... (2)
Boman, Johan, 1955 (2)
Andre, Malin (2)
Brune, Mats, 1950 (2)
Edling, Axel (2)
Andersson, Ingrid (2)
Hjelm, Katarina, 195 ... (2)
Löfmark, Rurik (2)
Mårtensson, Gunnar, ... (2)
Carlsson, Per, 1951- (2)
Msuya, Sia E. (2)
Lepp, Margret, 1954 (2)
Ljungstrom, L. (2)
Hassager, Christian (2)
Karlsson, Diana (2)
Ockborn, G. (2)
Nasic, S. (2)
Trollfors, B. (2)
Girma Kebede, Betleh ... (2)
Westphal Ladfors, Su ... (2)
Magnusson, David (2)
Dahlqvist, Rune (2)
Kumie, Abera (2)
Muhigirwa, B. (2)
Kashosi, T. (2)
Manegabe, J. T. (2)
Emgård, Matilda (2)
Samuelsson, Ebba, 19 ... (2)
visa färre...
Lärosäte
Göteborgs universitet (78)
Högskolan i Skövde (4)
Uppsala universitet (3)
Linköpings universitet (3)
Karolinska Institutet (2)
Umeå universitet (1)
visa fler...
Örebro universitet (1)
Lunds universitet (1)
visa färre...
Språk
Engelska (77)
Svenska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (64)
Samhällsvetenskap (8)
Humaniora (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy